BIOATLA, INC. Operating Lease Right-of-Use Assets
BIOATLA, INC. (BCAB) had Operating Lease Right-of-Use Assets of $5.08 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $5.08M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $5.31M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $5.53M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $5.75M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $5.08M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.31M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $5.53M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $5.75M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.00M 10-Q · filed 2026-08-13 | $5.97M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $258.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $512.00K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $763.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.01M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.25M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $1.50M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $1.73M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $1.97M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $2.20M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $2.42M 10-K · filed 2024-03-26 | |
| 2022-09-30 | $2.65M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $2.87M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $3.08M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $3.30M 10-K · filed 2023-03-23 | |
| 2021-01-01 | $4.10M 10-K · filed 2022-02-28 | |
| 2020-12-31 | $0.00 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |